Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 37 of about 34 companies and 17 funds for John Reed
Company Exchange Symbol Last price Quote change Market cap
Waddell & Reed Financial, Inc. NYSE WDR 39.16 -0.23 (-0.58%) 3.28B
Waddell & Reed Financial, Inc. is a mutual fund and asset management company. The Company provides investment management, investment advisory, ...
Executive:
John E. Sundeen Jr.
John Wiley & Sons Inc NYSE JW.A 52.05 +0.50 (0.97%) 3.05B
John Wiley & Sons, Inc. provides knowledge and knowledge-enabled services in the areas of research, professional practice and education.
Executive:
John A. Kritzmacher
THE REED INSTITUTE Private
Reed College offers bachelor's degrees in nearly 30 fields and a master of arts degree in liberal studies. Its special master's degree allows students to ...
Executive:
John R Kroger
John Wiley & Sons Inc NYSE JW.B 52.16 +2.38 (4.78%) 3.05B
John Wiley & Sons, Inc. provides knowledge and knowledge-enabled services in the areas of research, professional practice and education.
Executive:
John A. Kritzmacher
Intel Corporation NASDAQ INTC 28.42 +0.70 (2.53%) 135.11B
Intel Corporation is engaged in the design and manufacture of digital technology platforms. The Company sells these platforms to original equipment ...
Executive:
John Joseph Donahoe II
Verizon Communications Inc. NYSE VZ 46.04 -0.15 (-0.32%) 187.31B
Verizon Communications Inc. (Verizon) is a holding company that, acting through its subsidiaries, provides communications, information and entertainment ...
Executive:
John G. Stratton
Roche Holding Ltd. VTX ROG 263.20 -3.80 (-1.42%) 218.37B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John C. Reed MD, Ph.D.
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 34.16 -0.69 (-1.98%) 236.54B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John C. Reed MD, Ph.D.
NACCO Industries, Inc. NYSE NC 52.80 +0.84 (1.62%) 367.09M
NACCO Industries, Inc. is a holding company. The Company's subsidiaries operate in principal businesses, including mining, small appliances and specialty ...
Executive:
John C. Butler Jr.
Central Garden & Pet Co NASDAQ CENT 12.18 +0.13 (1.08%) 620.76M
Central Garden & Pet Company is a marketer and producer of branded products. The Company is the supplier of pet and lawn and garden supplies industries in ...
Executive:
John B. Balousek
Neometals Ltd ASX NMT 0.140 0.000 (0.00%) 71.27M
Neometals Ltd, formerly Reed Resources Ltd, is an Australia-based company. The Company is a minerals project developer. The Company's projects include: ...
Executive:
Christopher John Reed
General Cable Corporation NYSE BGC 14.74 +0.57 (4.02%) 721.10M
General Cable Corporation is engaged in the development, design, manufacture, marketing and distribution of copper, aluminum and fiber optic wire and cable ...
Executive:
John E. Welsh III
Aradigm Corporation NASDAQ ARDM 6.99 +0.04 (0.58%) 103.11M
Aradigm Corporation is a pharmaceutical company. The Company is focused on the development and commercialization of products for the treatment and ...
Executive:
John M. Siebert Ph.D.
Andersons Inc NASDAQ ANDE 35.20 +2.03 (6.12%) 985.60M
The Andersons, Inc. is an agriculture-focused diversified company. The Company conducts business in the grain, ethanol, plant nutrient and rail sectors.
Executive:
John J. Granato
Buckeye Technologies Inc. NYSE BKI 0.0000
Buckeye Technologies Inc. (Buckeye) is a producer of cellulose-based specialty products. The Company offers cellulose-based specialty products made from ...
Executive:
John B. Crowe
CSG Systems International, Inc. NASDAQ CSGS 31.14 +0.68 (2.23%) 1.02B
CSG Systems International, Inc. (CSG) is a provider of business support solutions primarily to the communications industry.
Executive:
John LM Hughes CBE
Roche Holding AG FRA RHO5
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John C. Reed MD, Ph.D.
Engility Holdings Inc Private
Engility Holdings, Inc. (Engility) provides a range of engineering, technical, analytical, advisory, training, logistics and support services.
Executive:
John P. Hynes Jr.
Roche Holding Ltd. (Bearer Share) SWX RO 263.75 -3.00 (-1.12%)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John C. Reed MD, Ph.D.
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John C. Reed MD, Ph.D.
Show all 34 companies »
Mutual Fund Symbol Nav Nav change
AllianzGI NFJ Mid-Cap Value Fund Class A PQNAX 24.82 +0.05 (0.20%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
AllianzGI NFJ Mid-Cap Value Fund Class C PQNCX 20.96 +0.04 (0.19%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
Consulting Group Large Cap Value Equity Fund TLVUX 12.46 +0.03 (0.24%)
The investment seeks total return, consisting of capital appreciation and dividend income. The fund normally invests at least 80% of its net assets (plus ...
Executive:
John R. Mowrey
Target Moderate Allocation M TARG_MODE_ALLO_1KF1146 11.21 -0.09 (-0.80%)
The investment seeks capital appreciation and a reasonable level of current income. The fund invests in a mix of equity and fixed-income securities ...
Executive:
John D. Crowley
AllianzGI NFJ Mid-Cap Value Fund Institutional Class PRNIX 26.29 +0.05 (0.19%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
Target Conservative Allocation M TARG_CONS_ALLO_141L9VD 10.44 -0.03 (-0.29%)
The investment seeks current income and reasonable level of capital appreciation . The fund invests in a mix of equity and fixed-income securities ...
Executive:
John D. Crowley
AllianzGI NFJ Mid-Cap Value Fund Class B PQNBX 22.12 +0.04 (0.18%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
Target Growth Allocation M TARG_GROW_ALLO_ESFNHW 10.75 -0.13 (-1.19%)
The investment seeks long-term capital appreciation. The fund invests in a mix of equity and fixed-income securities appropriate for a particular type of ...
Executive:
John D.
AllianzGI NFJ Mid-Cap Value Fund Class D PREDX 25.11 +0.05 (0.20%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
AllianzGI NFJ Mid-Cap Value Fund Class R PRNRX 21.79 +0.04 (0.18%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
AllianzGI NFJ Mid-Cap Value Fund Administrative Class PRAAX 25.52 +0.05 (0.20%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
Scout Global Equity Fund SCGLX 12.76 0.00 (0.00%)
The investment seeks long-term growth of capital. The fund pursues its objective by investing primarily in the equity securities of companies located ...
Executive:
Charles John
AllianzGI NFJ Mid-Cap Value Fund Class P ANRPX 20.87 +0.04 (0.19%)
The investment seeks long-term growth of capital and income. The fund seeks to achieve its investment objective by normally investing at least 80% of its ...
Executive:
John R. Mowrey
Virtus Alternative Total Solution Fund Class C VATCX 9.70 +0.02 (0.21%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
John B.
Virtus Alternative Total Solution Fund Class A VATAX 9.78 +0.02 (0.20%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
John B.
Virtus Alternative Total Solution Fund Class I VATIX 9.82 +0.03 (0.31%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
John B.
Virtus Alternative Total Solution Fund Class R6 VATRX 9.82 +0.02 (0.20%)
The investment seeks long-term capital appreciation through investments that have a low correlation to traditional asset classes.
Executive:
John B.